Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chinese Upcoming Revised Foreign Investment Catalogue Will Continue To Promote Innovative Drug R&D

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's State Council recently announced a plan to revise its Catalogue of Foreign Investment, which guides foreign investment and is, with this edition, opening more high-technology industries to foreign investment to encourage foreign companies to merge with and acquire Chinese firms engaged in high-tech industries
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

SC074382

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel